View Item 

Show simple item record

Polycomb group proteins EZH2 and EED directly regulate androgen receptor in advanced prostate cancer
dc.contributor.authorLiu, Qipeng
dc.contributor.authorWang, Guangyu
dc.contributor.authorLi, Qiaqia
dc.contributor.authorJiang, Weihua
dc.contributor.authorKim, Jung‐sun
dc.contributor.authorWang, Rui
dc.contributor.authorZhu, Sen
dc.contributor.authorWang, Xiaoju
dc.contributor.authorYan, Lin
dc.contributor.authorYi, Yang
dc.contributor.authorZhang, Lili
dc.contributor.authorMeng, Qingshu
dc.contributor.authorLi, Chao
dc.contributor.authorZhao, Dongyu
dc.contributor.authorQiao, Yuanyuan
dc.contributor.authorLi, Yong
dc.contributor.authorGursel, Demirkan B.
dc.contributor.authorChinnaiyan, Arul M.
dc.contributor.authorChen, Kaifu
dc.contributor.authorCao, Qi
dc.date.accessioned2019-05-31T18:26:22Z
dc.date.availableWITHHELD_15_MONTHS
dc.date.available2019-05-31T18:26:22Z
dc.date.issued2019-07-15
dc.identifier.citationLiu, Qipeng; Wang, Guangyu; Li, Qiaqia; Jiang, Weihua; Kim, Jung‐sun ; Wang, Rui; Zhu, Sen; Wang, Xiaoju; Yan, Lin; Yi, Yang; Zhang, Lili; Meng, Qingshu; Li, Chao; Zhao, Dongyu; Qiao, Yuanyuan; Li, Yong; Gursel, Demirkan B.; Chinnaiyan, Arul M.; Chen, Kaifu; Cao, Qi (2019). "Polycomb group proteins EZH2 and EED directly regulate androgen receptor in advanced prostate cancer." International Journal of Cancer 145(2): 415-426.
dc.identifier.issn0020-7136
dc.identifier.issn1097-0215
dc.identifier.urihttps://hdl.handle.net/2027.42/149265
dc.publisherJohn Wiley & Sons, Inc.
dc.subject.otherprostate cancer
dc.subject.otherEED
dc.subject.otherastemizole
dc.subject.otherEZH2
dc.subject.otherandrogen receptor
dc.titlePolycomb group proteins EZH2 and EED directly regulate androgen receptor in advanced prostate cancer
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelOncology and Hematology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/149265/1/ijc32118.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/149265/2/ijc32118_am.pdf
dc.identifier.doi10.1002/ijc.32118
dc.identifier.sourceInternational Journal of Cancer
dc.identifier.citedreferenceWei FZ, Cao Z, Wang X, et al. Epigenetic regulation of autophagy by the methyltransferase EZH2 through an MTORâ dependent pathway. Autophagy 2015; 11: 2309 â 22.
dc.identifier.citedreferenceSiegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin 2018; 68: 7 â 30.
dc.identifier.citedreferenceCzermin B, Melfi R, McCabe D, et al. Drosophila enhancer of Zeste/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal Polycomb sites. Cell 2002; 111: 185 â 96.
dc.identifier.citedreferenceMontgomery ND, Yee D, Chen A, et al. The murine polycomb group protein Eed is required for global histone H3 lysineâ 27 methylation. Curr Biol 2005; 15: 942 â 7.
dc.identifier.citedreferenceMcCabe MT, Ott HM, Ganji G, et al. EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2â activating mutations. Nature 2012; 492: 108 â 12.
dc.identifier.citedreferenceKnutson SK, Wigle TJ, Warholic NM, et al. A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells. Nat Chem Biol 2012; 8: 890 â 6.
dc.identifier.citedreferenceKnutson SK, Warholic NM, Wigle TJ, et al. Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2. Proc Natl Acad Sci USA 2013; 110: 7922 â 7.
dc.identifier.citedreferenceQi W, Chan H, Teng L, et al. Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation. Proc Natl Acad Sci USA 2012; 109: 21360 â 5.
dc.identifier.citedreferenceYap DB, Chu J, Berg T, et al. Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation. Blood 2011; 117: 2451 â 9.
dc.identifier.citedreferenceFillmore CM, Xu C, Desai PT, et al. EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitors. Nature 2015; 520: 239 â 42.
dc.identifier.citedreferenceBitler BG, Aird KM, Garipov A, et al. Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1Aâ mutated cancers. Nat Med 2015; 21: 231 â 8.
dc.identifier.citedreferenceYu J, Yu J, Mani RS, et al. An integrated network of androgen receptor, polycomb, and TMPRSS2â ERG gene fusions in prostate cancer progression. Cancer Cell 2010; 17: 443 â 54.
dc.identifier.citedreferenceXu K, Wu ZJ, Groner AC, et al. EZH2 oncogenic activity in castrationâ resistant prostate cancer cells is Polycombâ independent. Science 2012; 338: 1465 â 9.
dc.identifier.citedreferenceCao Q, Wang X, Zhao M, et al. The central role of EED in the orchestration of polycomb group complexes. Nat Commun 2014; 5: 3127.
dc.identifier.citedreferenceTrapnell C, Pachter L, Salzberg SL. TopHat: discovering splice junctions with RNAâ Seq. Bioinformatics 2009; 25: 1105 â 11.
dc.identifier.citedreferenceTrapnell C, Hendrickson DG, Sauvageau M, et al. Differential analysis of gene regulation at transcript resolution with RNAâ seq. Nat Biotechnol 2013; 31: 46 â 53.
dc.identifier.citedreferenceLiu YC, Morley M, Brandimarto J, et al. RNAâ Seq identifies novel myocardial gene expression signatures of heart failure. Genomics 2015; 105: 83 â 9.
dc.identifier.citedreferenceAsangani IA, Dommeti VL, Wang X, et al. Therapeutic targeting of BET bromodomain proteins in castrationâ resistant prostate cancer. Nature 2014; 510: 278 â 82.
dc.identifier.citedreferenceZhu S, Zhao D, Yan L, et al. BMI1 regulates androgen receptor in prostate cancer independently of the polycomb repressive complex 1. Nat Commun 2018; 9: 500.
dc.identifier.citedreferenceSpeers C, Zhao SG, Kothari V, et al. Maternal embryonic Leucine zipper kinase (MELK) as a novel mediator and biomarker of Radioresistance in human breast cancer. Clin Cancer Res 2016; 22: 5864 â 75.
dc.identifier.citedreferenceQi W, Zhao K, Gu J, et al. An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED. Nat Chem Biol 2017; 13: 381 â 8.
dc.identifier.citedreferenceKong X, Chen L, Jiao L, et al. Astemizole arrests the proliferation of cancer cells by disrupting the EZH2â EED interaction of polycomb repressive complex 2. J Med Chem 2014; 57: 9512 â 21.
dc.identifier.citedreferenceZhao JC, Yu J, Runkle C, et al. Cooperation between Polycomb and androgen receptor during oncogenic transformation. Genome Res 2012; 22: 322 â 31.
dc.identifier.citedreferenceRathkopf D, Scher HI. Androgen receptor antagonists in castrationâ resistant prostate cancer. Cancer J 2013; 19: 43 â 9.
dc.identifier.citedreferenceCao Q, Yu J, Dhanasekaran SM, et al. Repression of Eâ cadherin by the polycomb group protein EZH2 in cancer. Oncogene 2008; 27: 7274 â 84.
dc.identifier.citedreferenceYu J, Cao Q, Yu J, et al. The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer. Oncogene 2010; 29: 5370 â 80.
dc.identifier.citedreferenceCao Q, Mani RS, Ateeq B, et al. Coordinated regulation of polycomb group complexes through microRNAs in cancer. Cancer Cell 2011; 20: 187 â 99.
dc.identifier.citedreferenceBanerjee R, Mani RS, Russo N, et al. The tumor suppressor gene rap1GAP is silenced by miRâ 101â mediated EZH2 overexpression in invasive squamous cell carcinoma. Oncogene 2011; 30: 4339 â 49.
dc.identifier.citedreferenceChen H, Tu SW, Hsieh JT. Downâ regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer. J Biol Chem 2005; 280: 22437 â 44.
dc.identifier.citedreferenceKong D, Heath E, Chen W, et al. Loss of letâ 7 upâ regulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BRâ DIM. PLoS One 2012; 7: e33729.
dc.identifier.citedreferenceLee ST, Li Z, Wu Z, et al. Contextâ specific regulation of NFâ kappaB target gene expression by EZH2 in breast cancers. Mol Cell 2011; 43: 798 â 810.
dc.identifier.citedreferenceHe A, Shen X, Ma Q, et al. PRC2 directly methylates GATA4 and represses its transcriptional activity. Genes Dev 2012; 26: 37 â 42.
dc.identifier.citedreferenceKim E, Kim M, Woo DH, et al. Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stemâ like cells. Cancer Cell 2013; 23: 839 â 52.
dc.identifier.citedreferenceLee JM, Lee JS, Kim H, et al. EZH2 generates a methyl degron that is recognized by the DCAF1/DDB1/CUL4 E3 ubiquitin ligase complex. Mol Cell 2012; 48: 572 â 86.
dc.identifier.citedreferenceSanulli S, Justin N, Teissandier A, et al. Jarid2 methylation via the PRC2 complex regulates H3K27me3 deposition during cell differentiation. Mol Cell 2015; 57: 769 â 83.
dc.identifier.citedreferenceTan J, Yang X, Zhuang L, et al. Pharmacologic disruption of Polycombâ repressive complex 2â mediated gene repression selectively induces apoptosis in cancer cells. Genes Dev 2007; 21: 1050 â 63.
dc.identifier.citedreferenceMiranda TB, Cortez CC, Yoo CB, et al. DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation. Mol Cancer Ther 2009; 8: 1579 â 88.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
ijc32118.pdf
Size:
1.716MB
Format:
PDF
View/Open
Name:
ijc32118_am.pdf
Size:
7.360MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.